Dendrimer Prodrugs.

Molecules

Laboratory of Design and Synthesis of Chemotherapeutics Potentially Active in Neglected Diseases (LAPEN), Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo-USP, Avenue Professor Lineu Prestes, 580-Building 13, São Paulo SP, 05508-900, Brazil.

Published: May 2016

The main objective of this review is to describe the importance of dendrimer prodrugs in the design of new drugs, presenting numerous applications of these nanocomposites in the pharmaceutical field. Therefore, the use of dendrimer prodrugs as carrier for drug delivery, to improve pharmacokinetic properties of prototype, to promote drug sustained-release, to increase selectivity and, consequently, to decrease toxicity, are just some examples of topics that have been extensively reported in the literature, especially in the last decade. The examples discussed here give a panel of the growing interest dendrimer prodrugs have been evoking in the scientific community.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274429PMC
http://dx.doi.org/10.3390/molecules21060686DOI Listing

Publication Analysis

Top Keywords

dendrimer prodrugs
16
dendrimer
4
prodrugs main
4
main objective
4
objective review
4
review describe
4
describe dendrimer
4
prodrugs design
4
design drugs
4
drugs presenting
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!